|
Volumn 121, Issue 3, 2008, Pages 777-779
|
Recall antigen reactions in patients with atopic dermatitis treated with tacrolimus ointment for 1 year
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIGEN;
CORTICOSTEROID;
IMMUNOSUPPRESSIVE AGENT;
TACROLIMUS;
ATOPIC DERMATITIS;
CANCER RISK;
CLINICAL TRIAL;
DISEASE SEVERITY;
DRUG EFFECT;
DRUG INHIBITION;
FOLLOW UP;
HUMAN;
LETTER;
ORGAN TRANSPLANTATION;
PRIORITY JOURNAL;
SKIN CANCER;
SKIN TEST;
T LYMPHOCYTE;
TH1 CELL;
TREATMENT DURATION;
ULTRAVIOLET RADIATION;
VIRUS INFECTION;
ADULT;
CLINICAL TRIALS AS TOPIC;
CLONAL ANERGY;
DERMATITIS, ATOPIC;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
OINTMENTS;
SKIN;
T-LYMPHOCYTES;
TACROLIMUS;
|
EID: 40049085554
PISSN: 00916749
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jaci.2007.12.1179 Document Type: Letter |
Times cited : (9)
|
References (5)
|